☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
]
AstraZeneca’s Ultomiris (ravulizumab) Receive EC’s Approval for the Treatment of Generalised Myasthenia Gravis
September 26, 2022
Load more...
Back to Home